Patel Previews Collaborative Research Program With SD-101 in Uveal Melanoma
Season 5, Episode 14, Jun 10, 2021, 07:55 PM
Dr. Patel discusses the significance of the new collaboration between The University of Texas MD Anderson Cancer Center and TriSalus™ Life Sciences and the resulting research evaluating the administration of an investigational toll-like receptor 9 (TLR9) agonist in combination with immunotherapy across a range of liver and pancreatic solid tumors.